Page 1 A 150 IL 120 U) (0) 0 U 0 C) 0. i0 B U- 'a 'a 0 0 0 0) 0. 0 30 60 ...

2 downloads 0 Views 1MB Size Report
PLC treatment. (0.16-1.25. U!mL at 37#{176}Cfor 1 h) removed only the. GPI-anchored. CD14, resulting in reduced. CDI4 expression so that the amount of CDI4.
Effect of specific

A

inhibitors

on CD1 4-dependent

phagocytosis

150 IL

Phagocytosis

120

>>

U) (0)

90

0

of killed

presence was

U

of 10%

inhibited

.,

C)

30

LPS

to CD!4,

receptor 00

30

60

90

120

mAbs

(Fig.

1 i0

of

B 1

5).

There

and

kinase 90

‘a ‘a

60

250

250

(Fig.

V

30

-

6).

was

0.

9

60

90

CD14

Effect

cci P1-PLC

transfectants

and

LB P-opEc..

120

150

ability

P1-PLC

After

were

seen

and

with

mAb

63D3

tion,

whereas

cells (a P1 3-

with

expressioce

0.16 U/mL;

and

1.25 tJ/

PBS.

CL)14

measured.

rc’Con-

phagtecytosis

illustrates

was

one represen-

of two.

We

used

of

jiM

not

mAb

inhibit

CDI4-dependent

18E12

does

[9,

10,

the

two

transfected

amounts

of CD 14,

pression

by treating

PLC

treatment

only

the

we

cell

cell

activa-

a flow

human

LB P-opEc

devised

(0.16-1.25

U!mL

GPI-anchored so

CD14,

that

THPI-wtCDl4

the

cells cells.

The

Hl-PHS-

or

CD14

expression

Cl)14

anchorage both of C 1)14

resulting of

killed BODIPY,

LB P-opEc (r

fore

the

(Fig. the supported

4).

When

equal

levels

1 h) removed

of

the

was

kinase

seen

with

at

inof

protein

0.02-2

assay

THP1-

expression

cells

70Z/3

edly

enhances

1gM

expression other

jiM

to study

sta-

cell

with

nature

of the

expression

was

At

normally In

lines

expressing

activation

present

and

We

no has

show

Thus

all

functions, facilitate

that

initiate(s)

unique identified.

here

that

LBP

Schffet

inhibition

a!.

demonstrated murine

pre-B

CI)i4)

mark-

including

surface

shown

in

(WI-anchored

forms

of

well were

[13].

In

of the data

primary

this

has of

CD14-dependent

to

form

sup-

of CD14 that

for

of C 1)14 with

(an)

is to addi-

signaling.

the an

study,

able

transmemhrane

as

or support

suggest role

interaction of

studies

CD14

equally

available

also

phagocytosis

express

supstudies

either

function

been

and

in

regardless the

then

CDI4-dependent dose-response

cells

of E. co/i,

protein(s)

lines

it was

equally

THP-l

cell

cell

to LPS,

both

in-

of CDI4 Previous

CDI4

addition,

acidic associated

Gram-negative

well.

not

responses

[12].

anchor.

mCDI4

do

There-

endocytosis an

was forms

equally

that

and

opsonized

of

pH.

into

integral

GPI-anchored

C[)14

fluorescence

at acid

expression

of and

cellular

ligand

The

internalized

C 1)14

a or

BODIPY-conjugated

of phagocytosis be

cells,

a (WI-anchored

CD 14-transfected

(which

THP-i

quenched

of opEc of

LPS-induced tional

correlate

studies may

phagocytosis

bind

is not

GPI-linked

using

that

from

substrate.

phagocytosis

both

membrane by

phagocytosis

of phagocytosis.

for

phagocytosis

port

CDI4

transmembrane

FITC,

iransrnembrane

expressed

to

and

tyrosine

CDI4.

as the

compartment.

CD14-transfected

of the CD14

GPI-anchored

I-Il-

6). iNo inhibition

expressing

of human

substrate

LPS-induced

P1-PLC.

in reduced

found

regardless

of respectively,

(Fig.

derived

line,

used

enhanced

with

different

was

it is useful

ex-

to perform

was

= 0.9)

phagocytosis

phagocytosis

cell

unlike

P1-

that

of cells

at 25

shown).

lines

form

E. co/i

to normalize

CDI4

approximated

of

23 (a protein

cytometric

transmembrane

with

at 37#{176}C for

amount

ability

expressed

cells

71%

respectively

by THP1-wtCI)14,

not

cell

performed

a strategy

THP1-wtCDl4

and

wortmannin,

concentration

monocytic

ported

201.

lines

by 61

inhibition

tyrphostin

transfected

with does

inhibited

DISCUSSION

bly

Phagocytosis of opEc is correlated only with the amount of CD14 and not with the form of membrane anchorage

forms

= 2)

(n

of wortmannin

of

54%

(data

bacteria;

equivalent,

inhibition

THPI-

P1-PLC

were then

Each panel

0.

P1-PLC

twice

to

p

of

inhibitory

THP1-wtCDl4

by THP1-wtCDl4 cells inhibitor bisindolyl-maleimide

tracellular

tmCDl4

74% by

Phagocytosis

was

LBP-opEc

at 100

where

expression

anti-Fry

not

1.25

P1-PLC

U/mL;

0.62

(MEl)

C 1)14

0.16

P1-PLC

V, THP1-wtCi)14.

washed

regression.

linear

by

from

A, THPI-tmCDl4,

phagoc.yteesis

Icetweeme

experircueret

Because

and

were

and (B)

ranging

#{149}, THPI-wtCl)14,

cells

and

cceefficic’ret

determined tative

reblock

at 37#{176}C f(er 60

THPI-RSV,

,

PI-PLC

no P1-PLC;

incubating,

inculcated

were

mireP1-PLC;

0.31 U/mL;

expression

nc’latiore

84%, not

Icy THP-I

H l-PHS-opEc

(Sigma)

THPI-wtCI)14,

A, THPI-tmCl)l4.

(A)

P1-PLC;

no

#{149}. THPI-wtCl)14, U.

cells

cci P1-PLC

THPI-RSV,

0.

expression

ore C1)14

tee ingest

THP-I

ceencentraticens

U/mL

mnL.

and

concentrations

and

phagocytosis kinase C

(MFI)

treatment

their

Trarusfected

1.25 U/mI.

c:eptcer

63

concentrations

cells

concentrations

wtCI)14.

60.3,

197)

respectively.

A 67

hibitor)

I

30

0

1.25

a mean

nM

nM

PHS-opEc

0)

U/mL:

and

does

mAb

and

of HI-PHS-opEc

inhibitor),

and

0

with

lV.3,

was

by THP1-wtCDl4

.

0

mite

by 90

which

plasma

.

0

4.

in the

H1-EDTA

28C5

63D3,

anti-CI)18

(3G8,

phagocytosis

at 25

U-

Fig.

mAb

monocytes

10%

-

0.

0

normal and

14 mAb

Anti-CDI4

binding

by

plasma

by anti-CD

spectively.

0

E. co/i

EDTA

GPI-anchor

of

important

illustrated

role by

phagocytosis

phagocytosis

an with

in LBP

anti-

791

A 80 0>

--

00

20 I’

(-)

Ab:

Ag:

28C5

63D3

60.3

3G8

CD14

CD14

CD18

Fc?RllI

IV.3

Fc’yRII

197

Fig.

FciflI

5.

cytes

Pleagocytosis

in

the

Pleagocyteesis

cef monocytes

II

only

Icy nermal

inhibited

hey

as detennuined

refpositive cells where

B

K. cob

10% E DTA

of

plasnea (B) was

Hl-EE)TA 28C5.

eef killed

presence

coneupared was

monce-

plasnea (A) and anti-CDI4 neAb

by thee percentage

witle a contrcel ceensisting

mc’asured

after

1 h inculcation.

30 20

o

0.

10 0 Ab:

Ag:

LBP

CD14

antibody

viously

fragments.

that

plexes

that

coating

[4].

Of

nm,

binding

cytes

by

human

may

stem

from

note,

in

not

cytes

the

different

with

our

cell

CD14-dependent

cell

anti-CD14

that

18E12

inhibits

and

nuclear

results,

on

bulk

of

the

inhibits vation

and

tumor

dependent

binding

CD 14-dependent for

vides

the

792

Journal

10],

not

factor results

results:

release but

been

that

another

serves

machinery

Leukocyte

Biology

protein, for

Volume

plexes,

thus

pathway,

blocking

we

cytosis

of opEc

from

similar

extent

18G4

sCD14.

Furthermore,

inhibited

bound

but

inhibited

does

further

dependent

pro-

cation-chelating

1997

that

block

LPS

was

of

LBP-opEc

an

antibody

binding

it still

Phagoblocked

to

fragments was

occurred

it is

due

when

not binds

Finally, was

to Ig

LBP

was

serum. et

al.

occurs

have in

asserted

evidence phagocytosis

CD14-dependent

agent.

that

monocytes

via

CDI4-dependent a separate

phagocytosis to support

this

assertion.

is inhibited We,

along

phagocytosis

by with

pathway

[11]. EDTA,

occurs

We

pro-

Complement-

others,

a divalent have

in the

a

and

that

[20].

phagocytosis

because

comopsonic

F(ab’)2

63D3,

complement-dependent

mol-

signal-

cells

phagocytosis

satu-

immune

of experiments.

CD14-dependent for

to

of phagoto the

receptor-dependent

anti-CD14

14 mAb

not

FryRlI, CD14

inhibition secondary

THP1-wtCDl4 both

to bacteria

phagocytosis from

by

that

Grunwald re-

by

Fc

the

a number

by anti-CD

substituted

CD14-

an

performed

on

showed

3).

able

18G4

December

with

CD14/anti-CD14

previously

62,

FryRl,

with

KB acti-

transmembrane

the

we

of CDI8,

of Fc receptors

mAb

then

(Fig.

Based

mAbs,

cooperate

ration

unlikely

which

phagocytosis

to

used

CDI4

as a ligand-focusing

appear

that

effect

18E12

portions not

occurred

factor

Our

using

mAb

little

[10].

do

phagocytosis.

studies

possibility

shown

factor

and

inhibition

extramembrane

mediate

vide

transmembrane

necessary

of

CD14

FryRlIl

has

the not

the

and

necrosis

whereas

nuclear

parallel

18G4

mAb

it has but

that

attachment, of

by anti-CDI4

phagocytosis.

We postulate ecule

[9, but

necrosis

separated

tumor

cytoskeletal results

To disprove

by mono-

anti-LBP

KB activation

binding

phagocytosis LPS

with Previously

binding

substrates

be

ing, the

cytosis

results

et al. were

can

FcyRI

erythroOur

and

opso-

[11].

18E12.

LPS

as an

of E. co/i

LPS-stimulated

LBP-LPS

LBP

Grunwald

lines

factor

com-

macrophages

reported.

types

activation

mAb

release

ported

cell

by

to

of LPS-coupled was

pre-

opsonin

LPS-LBP

of

phagocytosis

CD14-dependent and

with

phagocytosis

monocytic

an

erythrocytes

phagocytosis

Fc’yRII

et al. have

as

description

CDI4-dependent and

acts

macrophages

Consistent

to show

of

FcyRlll

by Wright

LBP

initial

the

but

CD18

of erythrocytes

binding

enhances

[4].

Studies

demonstrated

showing

CD14

shown absence

cifically

A

inhibit

[24,

25].

P1

Recent

mannin

inhibits

actin-rich

and

inhibited

B

of Fry

phagocytic kinase

inhibitor

ment cc’lls

with

were’ incubated

was

then

LBP-opEc

for

30

In

(MEl)

[23]

and

our

system

did

not

23 kinases out

This

cations

by human

monocytes

l-II-EDTA

plasma

dent

phagocytosis

mAb

28C5

tor

mAbs

THPI-wtCDI4

not

60.3.

on

study

cations;

it was

13-chain

of CR3

and

of complement

phagocytosis.

fect

was

well

as

to

that

Indik

et

al.

P1

3-kinase

in

observed for

Fc’yRIIIA/’y mannin dose-dependent

at for

phagocytosis [22,

inhibited

have

were

is not

de-

This

work

in diva-

in the

clearance

a path

CR3,

CR4,

and

may

intercept by

can-

targets.

via

utilized

Grants

number

immunology was

10884-1MM

of The

supported

A115136

(P. 5. T.),

that with

Fe

is

Fcy

rethe

receptors

at

and

from

Scripps

by National

(R.

J. U.),

A101442

(D.

the

l)epart-

Research

Institute.

Institutes

GM28485

(R.

of Health

J. U.),

A132021

S.).

CD18, the

ab-

REFERENCES

opsonized

the

effect

of

COS-1

cells.

Wort-

complete

inhibition

ef-

phagocytosis through

CD14-dependent concentrations

now

and

that

wort-

report phagocytosis (nM)

in that

spe-

leer complexes

(LPS)

ccl lipopcelysaceIuaride.

3.

jima, M.. Glause’r, M.-P., ‘Rebias. P. S.. Ulevitchu, H. 1. (1994) pattern recognition rm’cr’1etcer. Immunity 1. 509-51 (c. Peterson. I K.. Gekker, C., Hu, S.. Anelc’rsone, W. H., Ulevitehu. bias, P. S., Gustafson, K. rc’ce1etor-mediated uptake by humace

4.

Wright.

micrccglia. S. I).,

feer reccegnition

infect.

Tohias,

popolysacchanidc’

as

Fc’yRI!y

H. A., Thheias, P. S.. tilevitele,H. I., Matleisen. I. C.

4. a recc’}etor

2.

of

This

S. 1).,Ramos. CI)1

LPS binding preeteins. Scie,eee 249. 1431-1433. Pugime. J.. Hc’irceeann, 1)., Tcereiasz. A., Knavmhe’nko,

in a dose-

concentrations.

\right. (1990)

FryR-

25

we

I.

intra-

on

almost nM

an

receptors

inhibitor,

FryRIIA-mediated

at

via Fcy

phagocytosis

Similarly,

fashion

of

in

studied

mediated

23].

of CD14

results

point.

is publication

ment

against

by

transfected

with

occurring

This but

require

occur

utilized

FryR-mediated

fashion

phagocytosis

not

mAbs

may

similar

phagocytosis

dependent

other

serum.

a specific inhibited

undetermined

28C5

it occurred

E. co/i

phagocytosis

wortmannin,

by

it occurred

killed

or heat-inactivated

mediated

does

and

our

on

protein

recep-

by monocytes

because by

CR4;

30],

at

and

ACKNOWLEDGMENTS

by anti-CI)14

inhibited

inhibited

25,

pathway pathway

in and

phagocytosis 3-kinase

by phagocytes

phagocytic signaling

as yet

phagocytosis

P1

receptors

protein

and

or anti-Fcy

phagocytosis

when

pathway

mannin

also

therefore

and

CDI4-dependent for

60.3

system

not

plasma

of LB P-opEc was

an

role

of

phagocytosis wortmannin

inhibitors the

hisindolyl-

activity

Although

[24,

of opsonic This

the

inhibit

bacteria

similar fash-

of

C 1)14-dependent

establishes

that

by

C1)14-dependent

of these

with

shown

FryR-mediated

specifically

of Gram-negative

manner have

in a dose-dependent

shown). to

FryR-

cation-indepen-

inhibited

18 mAb

complement

lent

cellular

of EDTA

CDI4-dependent

the

phagocytosis

divalent

significantly

of EDTA

LBP

This

anti-CD

the with

presence

5).

cells

presence

sence

We observed

5). Phagocytosis

Thus,

pendent the

was not

(Fig.

and

in the (Fig.

but

[11].

not

ri

decreases

inhibited

inhibit

inhibit

effects

intracellular divalent

23

de-

[26-28].

We was

inhibit

known

not

ceptors. of external

be

treatment

concentrations

inhibited

tyrosine rule

not

(data

independent

cseeasuned.

re-

inhibitors

23

[26-28].

completely do

concentrations

mneice, Phagocytosis

Fry both

phosphory-

a dose-dependent

p.M

contrast,

that C [29]

to tyrosine

kinase

phagocytosis

6).

tyrphostin

hibited

25

of tyrphostin

(Fig.

kinase

Pluagocytosis of LBF’-opEc Icy TH P1 -wtCI) 14 cells was inwith wortniannin (A) and tyrpleecstime 23 (B) .Aften Ienc.treatef cells with inleibiteer as descrilced in Materials amid Methccds,

into

that would

Furthermore,

tyrphostin in

at

maleimide

6.

of

closure

phagocytosis

phagocytosis

ion

23 (concentratIon)

tyrosine

rosine

concentrations

Tyrphostln

with

cells

inhibition

leads [23].

receptor-mediated

0 0 0) ‘a

6)

wort-

extension

their

unexpected

substrates

Fry

0

0.

(Fig. that

by inhibiting

phagocytosis

receptors

CD 14-dependent

U)

4-kinase

suggests

preventing

it is not

creases

50%

0)

Fig.

Thus,

of multiple

mediated U.

by

CD14-mediated

Activation

(concentratIon)

not

but

P1

et al.

by wortmannin.

lation of

not

Araki

phagocytosis [26].

ceptor-

but

by

pseudopods

phagosomes

Wortmannin

3-kinase

work

Y., NisleC1)I4

is a

Hi..

Ib-

..

Moliteer, ‘F. W.. Chac. C. C. (1995) C1)14 of nonopsonizeci Myeobacteriunn tuberemdosis Imneun.

P. S.,

(L.PS)

V., Akamatsu,

and

63, 1598-1602.

Ule’vitch,

Icineling

H.

preetcin

Icy a meovc’l nece.ptor

I.,

Hamems.

obescenizes

H. A.

ore cnaercepbuages.

J.

Li-

(1989)

l.PS-bearing Irje.

particles Med.

170.

123 1-1241. 5.

a

Wniglet.

S.

I)..

Ramos,

H. A., Hermaneewski-Vcesatka,

A., Hceckwell,

P., l)et-

mers. P. A. (1991) Activation of the adleesive capacity of CR3 ore rucutnophils by endctcexin: l)ependence ore lipopolysacclearide leimeclirug protein and Cf)14.J.Lrp.Med. 173. 1281-1286.

ScJtf[et

a!.

CD 14-dependent

phagocytosis

793

6.

Tobias. P. 5.. Sceldau, K.. Cegnen. J. A.. Mintz. I).. tilevitch. H. 1. (1995) Lipopolysaccluanidc’ binding prcetm.in-mediated ceemnplexaticen of hipopolysacchanimle with selulele CDI4. J. Biol. Chenm. 270. 10482-

ivermectin prcelee (4’’ 5.7 chineethyl-heodi1cy pncepnieenylive.rnec.ctin) in .4smembrane’s. Paru.sito!. 104, 549-555.

cans 19.

l.ow, M. C. (1989) Clyccsyl-phcesehatielylireeesineeI: cell surface prceteins. ElSE!! J. 3. 1600-1608.

20.

Viniyakosccl,

10488. 7.

Yu. 13., Wright. S. I). (1996) Catalytic properties of lipopcelysaccharide (E.PS) binding }crotein.‘l’nansfc’r of I.PS to scelubleCI)14. J. Rice!. Chenm. 271. 4100-4105.

8.

Luchi.

9.

ticenof bacterial lipcepcelysacehanidc’ by human 151. 959-969. Kirkland. 1’ Finley. F., I.m.turcq, I).. Moriarty.

M.,

Munfeerd,

H. J.. Tecleias. CDI4.J. Rio!. 10.

Gegner.

J.A.,

H. S. (1993)

P. S. (1993)

Bindiceg.

Analysis

of

internalization,

and

neutropleils.J. Inm:nuno!. 22. A.. l,ec’. J.-I)..

Ulevitch,

lipopolysacchanide

leinding

h)y

C!cenm. 268. 24818-24823. Ulevitch.

and clearance.

B.

I..

Tohias,

23. P. S. (1995)

I)emal reeles for I.BP

and

l.h’S

signal

J.

nmCl)14.

transduction

Btol.

C/rem.

270, 24.

5320-5325. 11.

(;ld.

U., Fame.X., Jack. H. S.. Workahemahu,

F.. Schutt.

C. (1996)

Moncerytes

hey a CDI4-dependent 12.

lee’, 1.-I).. l’ransfection tivity tein.

13.

14.

15. lb.

can

phagoryteese

I

mecleanisne.

C.,

Inmnmuno!.

Kallies.

A., Stelten.

grane-negative 157. 4l

to complexes

of lipo1eeelysacchanide 175, 1697-1705.

(LPS)

and

l.PS

Hi.

(1992) the serusi-

hindiceg

R.,

imeg technique. Martin, H. I.. tin,

Bassoc’. C-F.

internalizaticece:

(1992)

Bird Kusel.

1)istributicen

in tissues

eel the’

Flow

(1984)

cytoneetrie.

studies

neneatcede

a fluorescenece’

794

Martin,

Journal

R. I.,

Kusel.

S. J.. Minta. ivermectin

parasite’

J. H. (1992) On

of Leukocyte

Biology

N.,

Asearms

A..

prcelee.

Haccgland. beedipy

.sceunm. Parasizo!.

ivenmecRe’s. 78.

the’

clistrihutiomu

Volume

ccl a flmiorescent

62, December

1997

eel hunean

CI)14

requirc’d

3-kinase

M.

NI., Calle’gees.

A., Alenaleam,

R.,

I..

W. F., l)eemlge’. and selective

Crinde’y. C., Viahees. inleileiteen of phospleati-

in tIre’ corrtpletiort

J.

J. 296.

res1eccmeses. Biochenr.

NI. ‘I’.. Swanseeme,

I. A.

(1996)

297-301.

A role’

of maenopineecytcesis

leer pleosphoand

phagocytee-

135. 1249-1260. Park. 1.-C.. Murray. R. K.. Chien. P.. Danlcy, C.. Sclereiheer.A. 1).(1993) Cecreserved cytoplasmie tyrosine re’sidues of t1ecgamnua suheunit are re’quirm.d for a phagocytic signal mediated hey Fc’yltllIA. J. Chic. Incest. 92, Ce!!

Rio!.

2073-2079.

28.

29.

Indik. Z. K.. Pan. X. 9.. Iluaceg. M.-M.. McKenzie’. S. K.. l.c’vinson. A. I.. Schre’iber. A. 1). (1994) Icisertion of ey#{252}eplasmi. tyrosine. se.quences into thee’ nonphagocytic re’cepteer Fe’yRIIB establishes pheageecytie function. Bh,oc! 83, 2072-2080. Borenema, J. L)., Karnitz, I.. NI., Schrcecccs,H. A., Aleraheamee, H. ‘I’., Leihscen, P. 1. (1994) ceatural killer

quenchR. P.

H., Bc’nggnere.

in neutropleil

sis by macropheages. 27.

A region

her

Cancer Re’s. 54, 2419-2423. NI. P. (1993) Wortmarenin is a pote’metpheeespleatiimehileiteer: the neele eel 1ehueesphaticlylinmcsitol 3.4.5-

Jolensoru.

ule’ release

49. 315-32:3. J. H.. Hcebenison, eef a lluore’scent

using

Anaki, iraesitide

Pleagocyte’ C3-me’diate’cl attachrnecet

341-348. 18.

tris1ehcesphate 26.

I.ee,

Bjerknes.

43894399. Powis, C.. Bonjceukliace.

dylinositol-3-kinase. 25.Arearce. A.. Wymann. elylinosirol 3-kinase

prce-

J.-l).,Knavchcnkee, V.. Kirkland, T. N.. Han, I., Mackman. N.. Moriarty. A.. l.eturcq. D., Tecleias, P. 5., Ulevitch, Ri. (1993) CPI-anchorc’d cer intc.gralme’mleracee’fcenmnscr1Cl) 14 cnediate ideretiralcellular responses teeendotcexin. Proc. 1V0t1. lead. Sri. lISA 90. 9930-9934. Theofame, C.. He,rwitz. A. H., Williams. H. E.. Liu, I’.. Chace, 1..Birr, C.. Carnell, S. F., Meszanos. K.. Parent. I. B., Kasler, H., Abenle, S., Trccwn, P. V.., Cazzano-Santcerce. H. (1994) An amino-terminal fragment of hucnan lipeepolysaecharide-IeindicegFenote’inre’tains lipid A binding hut not Ci)14-suimulateery activity. J. Imncunol. 152. 3623-3629. V/ace. C. P.. Park, C. S.. l,au. B. H. 5. (1993) A rapid and sineple. reeicroflucerccmetric’phagceiytcesis assay. J. Incnmunoi. Meth. 162. 1-7.

‘U N. (1995)

anchcer

leerlipcepolysacchanidc’heinehing. J. Rica!. Chem. 270, :361-:368. Jack. R. S..Crunwald, U.. Stelter,F..Workalemahu, C., Schutt, C. (1995) Bothe membrane-bound aced soluble forrirs eel (:1)14 heind tee Cramnegative bacteria. Eon. J. Inmnmuno!. 25. 1436-1441. Ninoneiya, N., Hazeki, K., Fukui. Y.. Se’ya. T.. Okada. ‘I’.. Hazeki. 0.. Ui. M. (1994) Involvement ccl phosphatidylineesitol 3-kinasc’ ice Fr gamma receptor signaling. J. Rio!. Cimenr. 269. 22732-22737. Inehik, Z. K.. Park, 1.-C.. Hunter, S., Sclereiher. A. I). (1996) The molecular dissection of Fe’ ganemna rc’ceptccr mediated eIeagoeytcesis. Blood 86.

Ashe’ndel, C., Zalkow. I... Matter, C. 1. (1994) Wonemanceiru, a pot..nt

bacteria

19-4125.

Katie. K., Tobias. P. S.. Kirkland, 1’. N., Ulevitch, of C1J14 icetce 707./3 cells dramatically enhances

J. Lirp. Mcd.

and 17.

21.

deacyla-

S.. Kirkland.

a versatile’

30.

Teeullec,

Fe receptor sticeeulaiimen cells is associated with and

I).,

ce’ll-mm’diated

Pianetti.

kamue, NI., Baude’n,

P.. Coste’, V.. Becissin,

of ehospIuatim1ylicrc.sitol 3-kinase in preedeiru kicease’ C-irede’peredent graru-

eytotcexicity. H..

J. Exp. Mec!. 180. 1427-1435.

Bellevergue..

P., Beeursier,

P.. Crand-Pe’rnet, 1.. AjaE., l,eenieelle.

F., Duhamel.

L,

Charoce. D.. Kirilovsky, 1. (1991) The hisinclolylmeealeinnide CF l09203X is a potent and selective inhibitor eel proteime kinase’ C. J. Rio!. C/cern. 266, 1577 1-15779.

Effector molecules in expression of the antimicrobial activity of macrophages against Mycobacterium avium complex: roles of reactive nitrogen intermediates, reactive oxygen intermediates, and free fatty acids Tatsuya Satoshi Department

*

Izumo,

Abstract:

tive (FFA),

microbicidal

Immunology

reactive

oxygen avium (m’)

of

free

inhibitors

and

phospholipase

intermediates

(RO!)

A2,

of

nitric

indicating

oxide

roles

synthase

of

RO!,

or

RN!,

and

The

anti-MAC

either

RN!

Listeria

get

or

FFA

activity.

the

combinations

H202-halogenation

+

was

of gave

generated

system

was

by

murine

the

combined

activity

MAC

contact

and ter

ceased MAC

xanthine with

was

m4s

with

MAC

anti-Lm

+

but

ROl

observed

of

m-mediated phase after 804; !997.

university,

as a tarFFA

and

effect,

functions RN!

with

of m4s, FFA

killing

MAC

of

and

not

MAC

stimulation.

in

antiby

J. Leukoc.

Biol.

in early

62:

the

functions

nitrogen

important

roles

RNI

including in the

795-

below

2]. ef-

to

what

myco-

is

known

of antimycobacte-

the

oxide

although

strain [9]. killed that

ROI

found

production

MAC the

RNI

of impor-

against sensitivity

found

that

a

(H202-halogenation

and

was

also

previously

ability

M’cobacterjon,

known [3-7].

activity of

we system

of ms

MAC,

are

dependence

halogenation also

radicals

microbicidal

Second,

effectively

are functions

tuberculosis

(NO)

of m

reported

(RNI)

antimicrobial

Mycobacterium

nitric

H202-mediated

duce

[1,

resistance

intermediates

expression

[8],

We

devised

as antimicrobial

molecules

in

against

m4s

system)

re-

therapeutic

of ms.

play

been

describe

effector

and

of drug

been

role

of host

We

major

reactive

MAC

have

infec-

patients

effective

a central

expression

pathogens.

Abbneviaticnus:

collaborating

relatively

in the

tant

stimulation)

seen 1-24 h afwas initiated

participates the

cells

play

(MAC)

AIDS because

although regimens

(ms)

First,

ii].

af-

the

temporarily

fector

complex in

to treat

organisms,

as prophylactic

Macrophages

has

production

(MAC

organisms

as well

avium.

intractable

of MAC

murine

from 3 h and increased during the first 36 h and continued at least for 4 days. These findings suggest that RN! and FFA rather than RO! are important effectors action

Kajitani,*

Medical

encountered

somewhat

sistance

to

immediately

within 2 h. FFA release was stimulation. RN! production

of anti-MAC

Slcimane

frequently

are

rial

showed an antago!n addition, when

(3)

was

RN!

they

com-

oxidase-acetaldehyde

RN!,

potentiated.

peritoneal

ter

Hiroko

Mycobacterium

are

concerning

antagonism. used

a synergistic

whereas FFA + H202-halogenation nism in exerting bactericidal activity. ROl

an

(Lm)

tions

bacterial

a synergistic effect. system in combina-

showed

monocytogenes

organism,

RN!

bactericidal

of RN! with FFA showed the H202-halogenation

with

of Dermatology,

Disseminated

in murine for ROt

a significant

When

Sano,*

INTRODUCTION

complex (MAC) and the production of these

NaNO2acids), exhibited

tion

Chiaki

acids

FFA in m anti-MAC functions. (2) Acidified derived RN!, FFA (linolenic and arachidonic and the H202-mediated halogenation system bination However,

Shimizu,*

tDepartrneni

reac-

fatty

(1) Intracellular growth of MAC m4s was accelerated by scavengers

RN!

and

activities

(RN!),

Mycobacterium of macrophage

effectors. peritoneal or

studied

intermediates

and

and

of Microbiology

Sato,* Toshiaki Tomioka*

Japan

We

nitrogen

against mode

Akaki,*t, Katsumasa Dekio, and Haruaki

M.

tuberculosis

of MAC inversely

odium

[10,

strains

to

correlated

cone1elc’x;

inwith

ne,

macre)-

RNI.

reactive nitrogen intermediates; NO. nitric oxide: ROl. reactive cexygen interneediates; Lm, Lisieria rnonorytogenes; TNF-a, tuneon necrosis factor a; FFA. free fatty acids; PEA9, phospheolipase A9; N NI MA, BSA, hcovine serurci alhtcnein; SOD, su1eereexide clismutase; FBS, fe’tal beevirie’ senunu; XOA. xanthiree oxidase-acetaldehyde: CFU, colcerey-feerming units; FEC. penitoneal exudate cell; HBSS, Hanks’ balanced salt solution; CL, chemileumireescenee; NOS, nitric oxide synthase; iNOS, ireducible ruiphage;

oxide

tnic

symethase;

etharuesulforeie’ acid. Cornesporedence: and

Immuneclogy.

H EPES.

Hanuaki

N-2-hydncexyethyl1eipenazine-N’-2-

Tomioka. Medical

Shineane

Departme’nt

University,

cef Microbiology

Izumo.

Shimane

693,

1997:

accepted

June

Japan.

Key

Words:

11202-mediated

cidal

activity

. phosphoiipa.se

halogenation A2

.

nitric

oxide

system. . microbisyntha.se

Received

February

18.

1997;

revised

June,

9.

9, 1997.

Journal

of Leukocyte

Biology

Volume 62, December

1997

795

their

virulence

It is also

[12].

reported

that

H202

plays

portant roles in the expression of the bacteriostatic of murine peritoneal ms against a low-virulence M. avium pears

[13].

Therefore,

to participate

provided

that

plied

to ms.

11202-halogenation

in m-mediated

sufficient Third,

hibit

potent

antimycobacterial

found

that

were

more

virulent relationship

to

colonial

and that

FFA

liberated

due

to the

(PLA2)

play

important

cobacteriostatic study,

of RNI,

and

effective

linolenic MAC

because

membrane the tested

potent

[16].

tion/release m4s

when

in vitro

addition, RNI,

ROl,

we

were

stimulated

but

was

Moreover,

for

their

[19]

(HEPES),

ciii,

100

fetal

bovine

serum

used

for

culture.

units/mL cell

Bacterial

24

by

with

MAC

acetate

exhibit FFA

of produc-

mouse

peritoneal

organisms

tture

(1.0

METHODS

probe

te,st.

Tleey

Laboratories,

(serovar

with

were

was

mL)

infection

in

N-285

and

Middlebreecek

Listeria

MI).

Scey broth

100

CFU

for

and

MAC

tor

(serovar

16) were

identified 7H9

by DNA

medium

EGIJ

(Lm)

Inonorytogenes

(I)ifcce was

(l)ifco).

Mice Six-

to

Clea

Ccc., Osaka,

niree-week-old

tece-week-celd

female’

feneale

Kanagawa,

Japan

Special

agents

Linolenie

acid,

arud Zyneosan MO.

Chemicals

xanthine

acid

796

Chemical

Journal

Japan

eight-

Charles

tee

River,

Inc.,

St. Louis,

MO.

(SOD)

and

Canboxy-PTIO

Industries,

of Leukocyte

Sigma

purchased Othe’n

we’re Osaka,

Nc_

catalase’,

bovine

from

was

tetna-reiethylimidazoline-3-oxide-l-ecxyl)

Pure

from

eexidase.

quinacnine,

A were obtained

[tHiarachidonic

dismutase

from

expenimnelets,

obtained

5.5)

at 37#{176}Cfor

1-2

by treating

p.M

cef 20

FeSO.4,

serum

albecmin

Chemical from

American

agents,

including

Co., St.

p.M

cceunted

we,re

7H11

den

cells

62,

oxielase,

10

mixace-

mM

ethyle’nediaminetetnaacetic 5.5)

at 37#{176}C for 2 h. After residual numb ens of

agan anel tryptic

PECs

(3

into

X

soy agar

was poured

The

MAC-infected

reeL)

with

plates

plus

catalase,

CO2

imecuhator

dium

dodecyl

NMMA,

the

temperaturc

After

the

frcem

December

Zymosan

incubawith

0.1 -mL

portion

(1.5

2% cef

10#{176} CFU/

X

cultivaticen, 80

ccentaimling

restrltant

agents,

mn

including

on quinacrimec’ m

lysate’

was

20% lysate’

p.L eef 0.23% kept

mixed BSA.

was

S 01)

at 37#{176}C in a

cultures,

with Thee

see-

at room 120

p.L

number

counted

(en

of 7H

11

10 mL

of

FBS-RPMI

ter;

Falcon)

PECs (2 X 10 cells) were in a FBS-ceeated plastic culture at 37#{176}Cfor 2 h in a CO2 incubator. adluerent

scraped

cccllee,te,d

off

into

Icy subsequent

preparation of

by ms

A-induce’el

5%

gently

1997

a CO2

ielate’s.

su-

Wako

a

Falcon

washing

N-260

cef test

thee m

saline

in

(H BSS),

to the

added

feer 10 miii, and CFU

were

96-well;

culture, incubated at 37#{176}C washed again with 2% FBS-HBSS. then cultivated in tlee medium (0.2

addition

for 5 days.

ccf 1ehospleate-buffe.reel

FBS-RPMI

2 he. After

carleecxy-PTIO,

sulfate was

cf 5%

in-

han-

cell

neonolayer

were

rtes

give’n

hefcere

at 37#{176}Cin

fcer

iniracellulare

for 2 Ic,and

or withccut

nd,

incubated

salt solution M.

fromee reeice

(0 at-heetteer,eeel

air)

onto thee m

incubator

bacterial

and

humidified

containing

irea CO9

ire 0.1

cells)

NY)

ccelleeted

(1 mg) 4 days

A

wells

Ceerning,

CO9-95%e

the medium mL)

l0

neicrceeulture

Works, (5%

were

(PECs)

of Zyneosan

injection

balanced

ment

Volume

by the

activity

exudate

The

FBS-HBSS,

Japan.

Biology

killing in a reaction

Lmn, nespe’ctively.

anti-MAC

Ha-

(2-phenyl-4,4,5,5purchased

Ic. Bacterial

xarethune’

100

cef 10-20

cnM sodium

in 100

FeSOt

organisrees

g/mL

and

ecensisting

(1.0 mL) pM

measured

FBS-Hanks’

agar

acid,

de-

effectors. i’o

with other

1-10

RNI, FFA, and ROl production (NMMA),

Louis,

peroxide

mice

arachidonic

(BSA),

purchased

In some

also used.

monomethyl-L-arginine

diolahe’led

used.

CI3AIJN

were

mice

BALl3/e

were

Japan,

comhinc,d

and

Nal,

consisting

bacterial

ve,st.

16), and

MAC

grown

L)etroit,

in Tryptic

cultured

N-260

was

in an

M. arium N-254 (serecvar 9), N-265 (serovar; ncentypeable). N-339 (senovan 8), and N-445 (senovar 1) and Mycobacierium intracellulare 14),

MI))

effectors

acid in 100 mM sodiunu acetate’ buffer (pH individual tneattnecet of test cteicroorganisms,

Glass

patients

M (pH

system

taldehyde,

Organisms

from

ccf streptomy-

heat-inactivated

(vlv)

the H:O2-lealcegereatiecre system,

in a reactiemn cnixture

10-20

buffer

XOA

of

and

imectcbated

seeded

(serovar

p.g/mL

5%

Ccc,, Walkersville,

FFA,

Fe cer feer2 he when

Peniteenc’al

N-256

100

and

BioWhittaker

(FBS;

activities eef RNI,

trapenitoneal

isolated

C,

the FFA-mediated antimicrobial activity, tlue organisms (- 10#{176} CFU) were treated with 2.5 tee 25 p.g/mL eef FFA (linoleruic or anacluideenic acid) dissolved on finely e’mulsifie’d (Icy sonication) in 1.0 mL of 100 mM sodium acetate bteffer (pH 5.5) at 37#{176}C for 1-2 h. The antimicrobial activity ef a h12O2-Fe2-rnediated halogenation system was measured as fecllows. TIue test organisms (. l0’ CFU)

M

AND

glutamine.

killing by antimicrobial

1iM H202,

system.

MATERIALS

2 mM of penicillin

supple-

and the xanthine oxidase-acetaldehyde (XOA) system were measured as pne7viously described [10, 181 with some, neodifications. For measurement of the antimicrobial activity of RNI against MAC and Lrn, test organisms [- 10#{176} colony-forming units (CFU)] we,re treated with RNI generated in a neacticen mixture (1.0 mnL) containing 1.25 to 10 mg/mL of NaNO2 in 100mM sodium acetate buffer (pH 5.5) at

were

anti-

various

profiles

FFA

not

signifi-

18].

among

examined and

The

components

ms

activity

of they

[10, major

of murine

In

system

tested

the

activ-

a ROl-mediated alone

102)

were

are

anti-MAC

culture

as this

OH,

they

phospholipids

most

used

acids

acid

sulforcic

37#{176}Cfor

system.

killing

arachidonic

activity

A2

antimicrobial

because

11202,

1640 (Nissui Pharmaceutical Ccc.. Tokyo, Japan) with 25 mM N-2-hydnoxye’thylpiperazine-iV’-2-ethane-

terneine

was

in mycobacterial

and

pro-

mycobactericidal/my-

H202-halogenation

system

(02,

of MAC been

of phagocytic

anti-MAC

the

effector

molecules

a close

of phospholipase

m4

RPM! mented

Antimicncebial

[17].

we assessed system

microbicidal cantly

in

were

indicates resistance

Medium

previ-

of MAC

it has

action

ex-

than

phospholipids

roles

H202-halogenation ROl

from

We

killing

of FFA

hydrolytic

FFA,

15].

This

sup-

(FFA)

variants

Moreover,

mechanisms

In this ities

degree

are

acids

[14,

[16].

virulence.

vesicles

fatty

FFA-mediated

the

their

Fe2+

colonial

variants

between

organisms posed

SmD

susceptible SmT

free activity

avirulent

apkilling,

of catalytic

unsaturated

ously

reaction

mycobacterial

amounts

im-

activity strain of

of the m

nes

pncdeceaion

cells 20%

cenesisting FBS-RPMI

centniftcgatiore without

a rest

c)F antimicrobial

cultured

in

elisle (80-mm

diame-

After

nirusireg with

ccf more

than

90%

with

rubbe’n

peclicemen

and

g fcen 5

mm. The

fresh

at 250 period

were

effecteens.

used

ms

for

2%

were

measure-

RN!

production

of ms

RNI

productiore

of

latiecn

in

slight

meedifications.

1.0

mL

mL)

culture

of

in

wasluing tured

5%

previously

(5

coentaining

for and

nitrite,

In

the

were

alone lation

of

that

to

UV-killed

NO2-

was MAC

ire

16-mm

with ire 10/

X

Gniess

the

which

the

medium,

no

36

h of

during

supernatants

increased

and

the

at

absorptien MAC

organisms

significant

indicat-

the

under

ccenelitoere.

release

FFA

Measureme,nt

m4s

of

Test

FFA

nele,ase, (6

mns

pcrfoermed

was

as described

106 ce,lls) were

X

incubated

FBS-RPMI

3.0

of

mL

cells) ing

were

then

tJV-killed

CO2

incubateer

fluid

was

4

containing

cultured MAC

ire 0.2

(1 X

feer up toe 24 h. The

mc’astcne,d

eten

(Packarol

M4

chemilunrine.scence

M

production

by using

Instrument

c’ach

mL

of 10%

FBS-RPMI

10#{176}/mL) in rueicnocultune, radioactivity

a Tni-Carb

Co.,

to some scavengers),

itor]

[23],

Carboxy-PTIO

caused

contain-

(data to play

tivity

of murine

(pH

tc,st

To

examine

the

ROl

in m

7.4,

plee’nel

with 0.1 ciuL sieen of killed mixture

sured md,,

(5

and

a

in

was

l0

X

the

antimicrobial

red-free)

cef 1 mM

MAC

me,asuned

2, acidified

s1eectrom-

and

H202-halogenation

with

killing

containing luminol.

(1

phcetoe’missieen Iumi1eheetccneeter

X

of CL as felleews

ire terceis

The,n. l05/neL) dunireg

ire 0.8 mL

10 mM

HEPES

0.1

of bacterial

was

neL

added

inculcation

(Leemicceureter

of

[22]. HBSS

aced added stmspen-

to the incubation at 37#{176}C was mea-

ATP-237,

Toyo

the

or

these

the

basis

of

5-day

cul-

and

FFA

RNI,

of anti-MAC

Kagaker

not

ac-

shown).

fixed

MAC

was

observed

2B).

This

means

were

findings

mt race!-

M.

separate

experiments,

anti-MAC

activ-

H202-halogenation when

whereas

that

in were

Similar with

organisms

when

acid,

effective

efficacies

the

at 10 M,

effect

5.5

significant

Notably,

in Fig-

linolenic

tested In

of the

As shown [26],

manner.

displayed

and

profiles against

microbicidal

not

killed

was

effectors

were

FFA,

the

system.

Their

shown).

effectively

tericidal

these

at pH

they

also

of RN!, examined

RN!

when

(data

acid

centration

of

system N-265.

N-260 (data

we

a dose-dependent

arachidonic system

of participation

of a cell-free

obtained

no

Fe2+

added

was

sufficient

Fe2

con-

significant

bac-

at 1

amounts

or

5

of cata-

_____________F

None

Fig.

1.

Effects

gr(ewth +

on

after

ROl,

NaNO2-derived

in also

lulare ity

use

M. avium

1.tM (Fig.

iokyo).

O time

SOD

catainhib-

[24],

ms

expression

activity, activity

MAC

IL).

wo,ne’ suspended

modes

ure

were

cells)

ms.

anti-MAC

culture,

(CL) ef ROl

ms

peritoneal

plus

experiment,

m4s

Therefore, in the

of was

(NOS)

scavenger) on

of

ms

of SOD

In this

effects

roles

in

synthase

of cultured

shown).

some

effects

functions

Microbicidal activity of RNI, FFA, and ROl against MAC organisms

increased

Briefly.

not

seem

addition [NO

[25].

cytotoxic

the

growth

(NO-specific

morphology

into

scintillation

Creevc,

by the

on

anti-MAC

bacterial

inhibitor)

no

and

the

NMMA

(PLA2

recovery

The

extent

(ROI

at 37#{176}C in a

liberated

liquid

Dcewners

we,lls

ms.

lases

result

on

by Neve

in

p.Ci/mL cef [tulanachideenic acid (100 Ci/mmol) in a polyprdepylene tube (15 X 90 mm) at 37#{176}Cin a CO2 incubator lc)r 24 Fe. The resultant ms loaded with radioactive anachidonic acid were, thoroughly washe,d with 2% FB S-HBSS to remevc’ uceincoenpecrated [3H]arachidonic acid. The ms (2.5 X 10 10%

representative

inhibitors

peritoneal

tivation from

al. [21].

murine

agents cul-

the

metabolic

quinacrine

accumu-

cultivation, NO2

1 shows

Figure some

reagent,

measuring in

by

Roles of ROI, RNI, and FFA in the expression of m4 anti-MAC activity

there culat 37#{176}C in a

were wells

did not produce

c)rganisms

(2.5

culture

witlu

Icy

echeserved

ms

intervals,

react

thee same

MAC

resultant

experiment

in

were

cells)

accumu-

[201 incubated

at 37#{176}C for 3 h, followed

At

to

quantitated

corutnceh

cultured

the

4 days.

alleewed

was

ccentent nm.

up

of NO2 described

10

X

culture wells (Falcon) with 2% FBS-HBSS. The, in 1.0 mL of 5% FBS-RPMI

removed

et

as

FBS-RPMI

in terms

measured

16-mm

incuhatccr

ture

was

Te,st ms

were,

ing

ms

supennatant

CO2

550

RESULTS

fected

**

Catalase

of

with

thc, me,dium

(1,000 (0.5

NMMA

MAC

ccf seeme,

in

umeits/mL)

plus

=

3).

N-260

catalase

*,**

cometnol ms

(*P